ACR–ACNM–SNMMI PRACTICE PARAMETER FOR THE PERFORMANCE OF FLUORINE-18 FLUCICLOVINE PET/CT FOR RECURRENT PROSTATE CANCER
PREAMBLE
I. INTRODUCTION
II. INDICATIONS
III. QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL
A. Physician
III. QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL
B. Qualified Medical Physicist
III. QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL
C. Radiologic and Nuclear Medicine Technologist
III. QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL
D. Radiation Safety Officer
IV. PET/CT FOR PROSTATE CANCER EXAMINATION SPECIFICATIONS
IV. PET/CT FOR PROSTATE CANCER EXAMINATION SPECIFICATIONS
A. Patient Preparation
IV. PET/CT FOR PROSTATE CANCER EXAMINATION SPECIFICATIONS
B. Radiopharmaceutical
IV. PET/CT FOR PROSTATE CANCER EXAMINATION SPECIFICATIONS
C. CT Imaging Component
IV. PET/CT FOR PROSTATE CANCER EXAMINATION SPECIFICATIONS
D. PET Imaging Component
IV. PET/CT FOR PROSTATE CANCER EXAMINATION SPECIFICATIONS
E. PET/CT Fluciclovine Sample Protocol:
IV. PET/CT FOR PROSTATE CANCER EXAMINATION SPECIFICATIONS
F. Interpretation
V. EQUIPMENT SPECIFICATIONS
VI. DOCUMENTATION
VII. EQUIPMENT CONTROL
VIII. RADIATION SAFETY IN IMAGING
IX. QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION
ACKNOWLEDGEMENTS
Writing Committee – members represent their societies in the initial and final revision of this practice parameter
|
|
|
Committee on Practice Parameters – Nuclear Medicine and Molecular Imaging
(ACR Committee responsible for sponsoring the draft through the process)
Committee on Practice Parameters and Technical Standards
(ACR Committee responsible for sponsoring the draft through the process)
Comments Reconciliation Committee
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
REFERENCES